NASDAQ · Medical - Devices

SSII (SSII) Stock

$3.98 -0.25% NASDAQ: SSII Healthcare

Valuation

MetricValue
Price$3.98
Market Cap$796.52M
P/E Ratio-64.33
P/B Ratio20.33
P/S Ratio16.52
EPS (TTM)$-0.06
52-Week High$10.00
52-Week Low$3.11
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-31.58%
ROA-16.22%
ROCE-21.05%
Gross Margin-21.43%
Operating Margin-19.05%
Net Margin-20.70%
Debt/Equity0.05
Current Ratio1.88

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$1.0M$6.0M$21.0M$42.0M
Operating Profit$-1.0M$-6.0M$-21.0M$-19.0M$-8.0M
Net Profit$-1.0M$-6.0M$-21.0M$-19.0M$-12.0M
EPS$-0.52$-1.41$-0.16$-0.10$-0.06
Op Margin—-389.4%-351.5%-91.9%-19.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$7.0M$25.0M$42.0M$74.0M
Total Liabilities$0$10.0M$11.0M$29.0M$36.0M
Cash$0$0$7.0M$0$3.0M
Borrowings$0$8.0M$8.0M$18.0M$3.0M

Latest News

SS Innovations International (SSII) Strengthens Leadership as Global Robotic Surgery Expansion Gains Pace NewMediaWire · Jul 20, 2026 SS Innovations International (SSII) to Showcase SSi Mantra at Society of Robotic Surgery Annual Meeting NewMediaWire · Jul 17, 2026 SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026 GlobeNewswire · Jul 17, 2026 SS Innovations International (SSII) Appoints Sarah Romano as Chief Financial Officer NewMediaWire · Jul 15, 2026 SS Innovations (SSII) Announces Graduation of Inaugural Cardiac Robotic Surgery Training Class by Subsidiary SSICRS Insider Monkey · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$-6.0M$-15.0M$-10.0M$-19.0M
Investing Cash Flow$0$5.0M$-1.0M$-1.0M$-7.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$7.0M$0$3.0M
Free Cash Flow$0$-1.0M$-16.0M$-10.0M$-22.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-2.20%
Quick Ratio1.89
Interest Coverage-8.00
Return 1Y-47.88%
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AHCO $11.17 -0.45% 8.52 $1.52B 0.00%
CNMD $44.24 -0.02% 19.34 $1.33B 1.17%
ESTA $92.80 +0.28% -38.58 $2.73B 0.00%
OMCL $37.15 -1.33% 99.32 $1.69B 0.00%
OMDA $20.18 -1.61% -71.91 $1.20B 0.00%

About SSII

SSII is led by CEO Sudhir Prem Srivastava, employs 378 people, headquartered in US, publicly traded since 2018.

SSII stock trades at $3.98 with a market capitalization of $796.52M. The stock is valued at a price-to-earnings (P/E) ratio of -64.33, price-to-book of 20.33, price-to-sales of 16.52. Over the past 52 weeks the stock has ranged between $3.11 and $10.00, and currently trades 60.2% below its 52-week high.

On profitability, SSII generates a return on equity (ROE) of -31.58%, return on capital employed of -21.05%, an operating margin of -19.05%, a net profit margin of -20.70%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides